Scleritis is a condition marked by inflammation of the sclera, the tough outer layer of the eye. It causes intense eye pain, redness, and sometimes vision disturbances. The inflammation can manifest in different forms—such as anterior, posterior, or necrotizing—each varying in severity and location on the sclera. Often linked to systemic diseases like rheumatoid arthritis or lupus, scleritis necessitates a comprehensive eye examination for diagnosis, potentially supplemented by imaging or blood tests to uncover underlying causes. Treatment focuses on alleviating inflammation and managing symptoms with medications like NSAIDs, corticosteroids, or immunosuppressants. Severe cases may demand hospitalization for intensive therapy to mitigate vision loss risks and complications. Effective long-term management involves controlling the underlying condition to prevent recurrence. Early detection and swift intervention are vital for preserving eye health in scleritis cases.
Background: IgG4-Related Disease (IgG4-RD) is a chronic, immune-mediated fibroinflammatory condition recognized as a multisystem disorder, often presenting with organomegaly, fibrosis, and organ…
We describe the first reported case of granulomatosis polyangiitis (GPA)-associated sclerokeratitis in a patient with treated ocular adnexal lymphoma (OAL). The patient presented with pain and…
We describe the first reported case of granulomatosis polyangiitis (GPA)-associated sclerokeratitis in a patient with treated ocular adnexal lymphoma (OAL). The patient presented with pain and…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Scleritis work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Scleritis research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Scleritis track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Scleritis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Scleritis are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Scleritis track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
